Aura Pharma

Aura Pharma, whose legal entity has been reported as FG Brasil LTDA and whose website now identifies the business as Aura Pharma S.A., is a Brazilian pharmaceutical company focused on cannabis-based medicines. The company develops, imports, markets, and supports prescription cannabinoid products for use under Brazilian regulatory frameworks, with commercialization through pharmacies and drugstores. Publicly available evidence indicates a portfolio centered on cannabidiol and cannabis extract formulations, plus at least one company-sponsored clinical study in fibromyalgia using a cannabidiol + tetrahydrocannabinol oral solution. The business appears to emphasize pharmaceutical-grade quality, GMP-aligned processes, and scientific support for prescribers rather than a broad discovery-stage biotech pipeline. Overall, Aura Pharma is best characterized as a specialty pharmaceutical company in medical cannabis rather than a traditional platform biotech.